A trial to look at how different doses of felodipine are tolerated in people with early-stage Huntington’s disease
FELL-HD · Cambridge Clinical Trials Unit
Phase 2 study testing felodipine to assess its safety and tolerability in people with Huntington's disease.
Recruitment endedPhase 2Not specifiedISRCTNTreatment trial
Recruiting in: United KingdomExact site not listed by the study registry.
Preparing a short plain-English summary.
